Literature DB >> 7114922

Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity.

J K Wright, P Hughes, N R Rowell.   

Abstract

Spontaneous (NK cell) and antibody-dependent (K cell) cytotoxicity were investigated in 39 patients with systemic sclerosis (SS) and compared with that found in 52 normal controls. Cr-labelled Chang liver cells were used as targets in assays utilising both whole blood (WB) and peripheral blood mononuclear cells (PBM) as effectors. Patients with SS, who were severely affected by extensive visceral disease, were found to have significant impairment of both NK (p less than 0.005; p less than 0.05) and K (p less than 0.001; p less than 0.05) cell cytotoxicity by both effector systems, when compared with normal controls. These findings, which seem to be part of a wider defect in cell-mediated immunity, may provide a possible explanation for the described association of malignancy with systemic sclerosis.

Entities:  

Mesh:

Year:  1982        PMID: 7114922      PMCID: PMC1000960          DOI: 10.1136/ard.41.4.409

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  ANTINUCLEAR AND PRECIPITATING AUTOANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS.

Authors:  J S BECK; J R ANDERSON; K G GRAY; N R ROWELL
Journal:  Lancet       Date:  1963-12-07       Impact factor: 79.321

2.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder.

Authors:  S Currie; M Saunders; M Knowles
Journal:  Br J Dermatol       Date:  1971-05       Impact factor: 9.302

4.  The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.

Authors:  P Hughes; S Holt; N R Rowell; I D Allonby; K Janis; J K Dodd
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

5.  Localized scleroderma-like lesions after bone marrow transplantation in man. A chronic graft versus host reaction.

Authors:  W A Van Vloten; E Scheffer; L J Dooren
Journal:  Br J Dermatol       Date:  1977-04       Impact factor: 9.302

6.  Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).

Authors:  H Kondo; B S Rabin; G P Rodnan
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

7.  Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors:  N F Rothfield; G P Rodnan
Journal:  Arthritis Rheum       Date:  1968-10

8.  Uracil-specific anti-R.N.A. antibodies in scleroderma.

Authors:  D Alarcón-Segovia; E Fishbein; E García-Ortigoza; S Estrada-Parra
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

9.  Sclerodermatous graft-versus-host disease limited to an area of measles exanthem.

Authors:  J R Fenyk; C M Smith; P I Warkentin; W Krivit; R W Goltz; J E Neely; M E Nesbit; N K Ramsay; P F Coccia; J H Kersey
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  HOMOLOGOUS DISEASE IN THE ADULT RAT, A MODEL FOR AUTOIMMUNE DISEASE. I. GENERAL FEATURES AND CUTANEOUS LESIONS.

Authors:  P STASTNY; V A STEMBRIDGE; M ZIFF
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.

Authors:  M Grazia Cifone; R Giacomelli; G Famularo; R Paolini; C Danese; T Napolitano; A Procopio; A M Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

Authors:  A Uddhammar; G Roos; B Näsman; S R Dahlqvist
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

4.  Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis.

Authors:  S Majewski; M Wasik; S Jabłońska; M Kamiński; M Fraczykowska
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.